会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Analog of haemophilus HIN47 with reduced protease activity
    • 具有降低的蛋白酶活性的嗜血杆菌HIN47的类似物
    • US5939297A
    • 1999-08-17
    • US296149
    • 1994-08-26
    • Sheena M. LoosmoreYan-Ping YangPele ChongRaymond P. OomenMichel H. Klein
    • Sheena M. LoosmoreYan-Ping YangPele ChongRaymond P. OomenMichel H. Klein
    • A61K39/00A61P31/04C07K14/285C12N9/52C12N15/31C12N15/57
    • C12N9/52C07K14/285A61K39/00C07K2319/00
    • An isolated and purified analog of Haemophilus influenzae Hin47 protein has a decreased protease activity which is less than about 10% of that of natural Hin47 protein and preferably substantially the same immunogenic properties as natural Hin47 protein. An isolated an purified nucleic acid molecule encoding the Hin47 analog may be provided in a recombinant plasmid which may be introduced into a cell which is grown to produce the Hin47 analog. Immunogenic compositions comprising the Hin47 analog and the encoding nucleic acid may be formulated as vaccines for in vivo administration to a host, including a human, to confer protection against diseases caused by a bacterial pathogen, including Haemophilus species, such as Haemophilus influenzae, that produces Hin47 protein or a protein capable of inducing antibodies in the host specifically reactive with Hin47 protein. The Hin47 analog and the encoding nucleic acid also may be employed in diagnostic applications.
    • 分离和纯化的流感嗜血杆菌Hin47蛋白的类似物具有降低的蛋白酶活性,其小于天然Hin47蛋白的约10%,优选与天然Hin47蛋白基本相同的免疫原性。 可以在重组质粒中提供分离的纯化的编码Hin47类似物的核酸分子,所述重组质粒可以被引入生长以产生Hin47类似物的细胞中。 包含Hin47类似物和编码核酸的免疫原性组合物可以配制成用于体内施用于宿主(包括人)的疫苗,以赋予针对由细菌病原体(例如流感嗜血杆菌)产生的细菌病原体引起的疾病的保护, Hin47蛋白或能够诱导与Hin47蛋白特异性反应的宿主中的抗体的蛋白质。 Hin47类似物和编码核酸也可用于诊断应用。
    • 4. 发明授权
    • Analog of Haemophilus Hin47 with reduced protease activity
    • 具有减少的蛋白酶活性的嗜血杆菌Hin47的类似物
    • US6147057A
    • 2000-11-14
    • US106466
    • 1998-06-30
    • Sheena M. LoosmoreYan-Ping YangPele ChongRaymond P. OomenMichel H. Klein
    • Sheena M. LoosmoreYan-Ping YangPele ChongRaymond P. OomenMichel H. Klein
    • A61K39/00A61P31/04C07K14/285C12N9/52A01N43/04
    • C07K14/285C12N9/52A61K2039/51A61K39/00C07K2319/00
    • An isolated and purified analog of Haemophilus influenzae Hin47 protein has a decreased protease activity which is less than about 10% of that of natural Hin47 protein and preferably substantially the same immunogenic properties as natural Hin47 protein. An isolated an purified nucleic acid molecule encoding the Hin47 analog may be provided in a recombinant plasmid which may be introduced into a cell which is grown to produce the Hin47 analog. Immunogenic compositions comprising the Hin47 analog and the encoding nucleic acid may be formulated as vaccines for in vivo administration to a host, including a human, to confer protection against diseases caused by a bacterial pathogen, including Haemophilus species, such as Haemophilus influenzae, that produces Hin47 protein or a protein capable of inducing antibodies in the host specifically reactive with Hin47 protein. The Hin47 analog and the encoding nucleic acid also may be employed in diagnostic applications.
    • 分离和纯化的流感嗜血杆菌Hin47蛋白的类似物具有降低的蛋白酶活性,其小于天然Hin47蛋白的约10%,优选与天然Hin47蛋白基本相同的免疫原性。 可以在重组质粒中提供分离的纯化的编码Hin47类似物的核酸分子,所述重组质粒可以被引入生长以产生Hin47类似物的细胞中。 包含Hin47类似物和编码核酸的免疫原性组合物可以配制成用于体内施用于宿主(包括人)的疫苗,以赋予针对由细菌病原体(例如流感嗜血杆菌)产生的细菌病原体引起的疾病的保护, Hin47蛋白或能够诱导与Hin47蛋白特异性反应的宿主中的抗体的蛋白质。 Hin47类似物和编码核酸也可用于诊断应用。
    • 5. 发明授权
    • Analog of Haemophilus Hin47 with reduced protease activity
    • 具有减少的蛋白酶活性的嗜血杆菌Hin47的类似物
    • US6114125A
    • 2000-09-05
    • US106468
    • 1998-06-30
    • Sheena M. LoosmoreYan-Ping YangPele ChongRaymond P. OomenMichel H. Klein
    • Sheena M. LoosmoreYan-Ping YangPele ChongRaymond P. OomenMichel H. Klein
    • A61K39/00C07K14/285C12N9/52C12N15/31G01N33/53
    • C07K14/285C12N9/52A61K2039/51A61K39/00C07K2319/00
    • An isolated and purified analog of Haemophilus influenzae Hin47 protein has a decreased protease activity which is less than about 10% of that of natural Hin47 protein and preferably substantially the same immunogenic properties as natural Hin47 protein. An isolated an purified nucleic acid module encoding the Hin47 analog may be provided in a recombinant plasmid which may be introduced into a cell which is grown to produce the Hin47 analog. Immunogenic compositions comprises the Hin47 analog and the encoding nucleic acid may be formulated as vaccines for in vivo administration to a host, including a human, to confer protection against diseases caused by a bacterial pathogen, including Haemophilus species, such as Haemophilus influenzae, that produces Hin47 protein or a protein capable of inducing antibodies in the host specifically reactive with Hin47 protein. The Hin47 analog and the encoding nucleic acid also may employed in diagnostic applications.
    • 分离和纯化的流感嗜血杆菌Hin47蛋白的类似物具有降低的蛋白酶活性,其小于天然Hin47蛋白的约10%,优选与天然Hin47蛋白基本相同的免疫原性。 可以在重组质粒中提供编码Hin47类似物的分离的纯化核酸模块,其可以被引入生长以产生Hin47类似物的细胞中。 免疫原性组合物包含Hin47类似物,并且编码核酸可以配制成用于体内施用于宿主(包括人)的疫苗,以赋予针对由细菌病原体(例如流感嗜血杆菌)产生的细菌病原体引起的疾病的保护, Hin47蛋白或能够诱导与Hin47蛋白特异性反应的宿主中的抗体的蛋白质。 Hin47类似物和编码核酸也可用于诊断应用。
    • 7. 发明授权
    • Analog of haemophilus hin47 with reduced protease activity
    • 具有减少的蛋白酶活性的嗜血杆菌hin47的类似物
    • US5869302A
    • 1999-02-09
    • US487167
    • 1995-06-07
    • Sheena M. LoosmoreYan-Ping YangPele ChongRaymond P. OomenMichel H. Klein
    • Sheena M. LoosmoreYan-Ping YangPele ChongRaymond P. OomenMichel H. Klein
    • A61K39/00A61P31/04C07K14/285C12N9/52C12N15/31C12N15/57
    • C12N9/52C07K14/285A61K39/00C07K2319/00
    • An isolated and purified analog of Haemophilus influenzae Hin47 protein has a decreased protease activity which is less than about 10% of that of natural Hin47 protein and preferably substantially the same immunogenic properties as natural Hin47 protein. An isolated an purified nucleic acid molecule encoding the Hin47 analog may be provided in a recombinant plasmid which may be introduced into a cell which is grown to produce the Hin47 analog. Immunogenic compositions comprising the Hin47 analog and the encoding nucleic acid may be formulated as vaccines for in vivo administration to a host, including a human, to confer protection against diseases caused by a bacterial pathogen, including Haemophilus species, such as Haemophilus influenzae, that produces Hin47 protein or a protein capable of inducing antibodies in the host specifically reactive with Hin47 protein. The Hin47 analog and the encoding nucleic acid also may be employed in diagnostic applications.
    • 分离和纯化的流感嗜血杆菌Hin47蛋白的类似物具有降低的蛋白酶活性,其小于天然Hin47蛋白的约10%,优选与天然Hin47蛋白基本相同的免疫原性。 可以在重组质粒中提供分离的纯化的编码Hin47类似物的核酸分子,所述重组质粒可以被引入生长以产生Hin47类似物的细胞中。 包含Hin47类似物和编码核酸的免疫原性组合物可以配制成用于体内施用于宿主(包括人)的疫苗,以赋予针对由细菌病原体(例如流感嗜血杆菌)产生的细菌病原体引起的疾病的保护, Hin47蛋白或能够诱导与Hin47蛋白特异性反应的宿主中的抗体的蛋白质。 Hin47类似物和编码核酸也可用于诊断应用。
    • 10. 发明授权
    • Analog of Haemophilus Hin47 with reduced protease activity
    • 具有减少的蛋白酶活性的嗜血杆菌Hin47的类似物
    • US5981503A
    • 1999-11-09
    • US615271
    • 1996-06-20
    • Sheena M. LoosmoreYan-Ping YangPele ChongRaymond P. OomenMichel H. Klein
    • Sheena M. LoosmoreYan-Ping YangPele ChongRaymond P. OomenMichel H. Klein
    • A61K39/00C07K14/285C12N9/52C12N15/11
    • C12N9/52C07K14/285A61K39/00C07K2319/00
    • An isolated and purified analog of Haemophilus influenzae Hin47 protein has a decreased protease activity which is less than about 10 % of that of natural Hin47 protein and preferably substantially the same immunogenic properties as natural Hin47 protein. An isolated an purified nucleic acid molecule encoding the Hin47 analog may be provided in a recombinant plasmid which may be introduced into a cell which is grown to produce the Hin47 analog. Immunogenic compositions comprising the Hin47 analog and the encoding nucleic acid may be formulated as vaccines for in vivo administration to a host, including a human, to confer protection against diseases caused by a bacterial pathogen, including Haemophilus species, such as Haemophilus influenzae, that produces Hin47 protein or a protein capable of inducing antibodies in the host specifically reactive with Hin47 protein. The Hin47 analog and the encoding nucleic acid also may be employed in diagnostic applications.
    • PCT No.PCT / CA95 / 00434 Sec。 371日期:1996年6月20日 102(e)日期1996年6月20日PCT提交1995年7月21日PCT公布。 公开号WO96 / 03506 日期1996年2月8日分离和纯化的流感嗜血杆菌Hin47蛋白的类似物具有降低的蛋白酶活性,其小于天然Hin47蛋白的约10%,优选与天然Hin47蛋白基本相同的免疫原性。 可以在重组质粒中提供分离的纯化的编码Hin47类似物的核酸分子,所述重组质粒可以被引入生长以产生Hin47类似物的细胞中。 包含Hin47类似物和编码核酸的免疫原性组合物可以配制成用于体内施用于宿主(包括人)的疫苗,以赋予针对由细菌病原体(例如流感嗜血杆菌)产生的细菌病原体引起的疾病的保护, Hin47蛋白或能够诱导与Hin47蛋白特异性反应的宿主中的抗体的蛋白质。 Hin47类似物和编码核酸也可用于诊断应用。